We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$237M
AUM Growth
+$55.9M
Cap. Flow
+$50.9M
Cap. Flow %
21.44%
Top 10 Hldgs %
68.51%
Holding
729
New
76
Increased
83
Reduced
120
Closed
343

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
MAR icon
Marriott International
MAR
+$14.1M
3
VAC icon
Marriott Vacations Worldwide
VAC
+$6.92M
4
HDV
iShares Core High Dividend ETF
HDV
+$3.92M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$2.86M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.93M
2
EFOR
Everforth Inc
EFOR
+$1.81M
3
F icon
Ford
F
+$1.74M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.05M
5
XYL icon
Xylem
XYL
+$747K

Sector Composition

Rank Sector Weight
1 Financials 23.74%
2 Consumer Discretionary 10.93%
3 Technology 10.32%
4 Healthcare 4.2%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JQC icon
526
Nuveen Credit Strategies Income Fund
JQC
$705M
– –
-2,122
Closed -$18K
KIO
527
KKR Income Opportunities Fund
KIO
$450M
– –
-669
Closed -$11K
KMI icon
528
Kinder Morgan
KMI
$70.9B
– –
-61
Closed -$1K
L icon
529
Loews
L
$24.5B
– –
-8
Closed –
LDOS icon
530
Leidos
LDOS
$14.4B
– –
-82
Closed -$4K
LEA icon
531
Lear
LEA
$7.39B
– –
-9
Closed -$1K
LEN icon
532
Lennar Class A
LEN
$20.4B
– –
-13
Closed -$1K
LGND icon
533
Ligand Pharmaceuticals
LGND
$5.77B
– –
-6
Closed –
LH icon
534
Labcorp
LH
$25.2B
– –
-12
Closed -$1K
LKFN icon
535
Lakeland Financial Corp
LKFN
$1.57B
– –
-37
Closed -$2K
LOW icon
536
Lowe's Companies
LOW
$121B
– –
-26
Closed -$2K
LUMN icon
537
Lumen
LUMN
$6.43B
– –
-51
Closed -$1K
LVS icon
538
Las Vegas Sands
LVS
$32.2B
– –
-251
Closed -$14K
MAC icon
539
Macerich
MAC
$7.4B
– –
-17
Closed -$1K
MBOT icon
540
Microbot Medical
MBOT
$112M
$0 ﹤0.01%
20
-5
-20% -$276
MCHP icon
541
Microchip Technology
MCHP
$38.8B
– –
-126
Closed -$5K
MDT icon
542
Medtronic
MDT
$112B
– –
-108
Closed -$9K
MGEE icon
543
MGE Energy Inc
MGEE
$3.03B
– –
-26
Closed -$2K
MHI
544
DELISTED
Pioneer Municipal High Income Fund
MHI
– –
-625
Closed -$7K
MKC icon
545
McCormick & Company Non-Voting
MKC
$14B
– –
-38
Closed -$2K
MRSH
546
Marsh
MRSH
$94.3B
– –
-23
Closed -$2K
MNST icon
547
Monster Beverage
MNST
$95.1B
– –
-48
Closed -$1K
MOS icon
548
The Mosaic Company
MOS
$7.19B
– –
-46
Closed -$1K
MSD
549
Morgan Stanley Emerging Markets Debt Fund
MSD
$146M
– –
-2,626
Closed -$25K
MSCI icon
550
MSCI
MSCI
$42.4B
– –
-4
Closed –
20 21
22
23 24

Similar funds

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
API
Advisor Partners II Walnut Creek, California $2.49B AUM 30.88% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
SCH
Sylebra Capital (HK) Hong Kong $1.88B AUM 19.75% 1-Year Est. Return
PWAG
Polaris Wealth Advisory Group San Rafael, California $1.31B AUM 17.95% 1-Year Est. Return
CS
Comerica Securities Detroit, Michigan $1.2B AUM 16.58% 1-Year Est. Return
IWP
Icon Wealth Partners Houston, Texas $880M AUM
MAM
Mastrapasqua Asset Management Nashville, Tennessee $853M AUM 37.36% 1-Year Est. Return

Pathstone Family Office's Q2 2017 Portfolio in Review

As of Q2 2017, Pathstone Family Office held 729 positions worth $237M, up 31% from $181M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Pathstone Family Office deployed $50.9M of net new capital in Q2 2017, opening 76 new positions and adding to 83 existing holdings. Its largest new stake was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.93M trimmed.

  • Pathstone Family Office's largest Q2 2017 buy was iShares Core High Dividend ETF: 233,470 shares worth $3.88M.
  • Pathstone Family Office added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $18.4M increase.
  • Pathstone Family Office's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.93M.
  • Pathstone Family Office fully exited Ford in Q2 2017, selling an estimated $1.74M.
  • Pathstone Family Office's ten largest holdings make up 69% of its $237M portfolio in Q2 2017.
  • Pathstone Family Office opened 76 new positions and closed 343 in Q2 2017.
  • Pathstone Family Office's portfolio value rose 31% quarter-over-quarter to $237M.

Based on Pathstone Family Office's 13F filing for Q2 2017, filed 11 Aug 2017.